Year: 2022

SÃO PAULO, Brazil, Nov. 21, 2022 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), Latin America’s first fully integrated data platform, today announced it will release its financial results for the third quarter of 2022, which ended on September 30, 2022, following the close of the U.S. markets on Tuesday, November 29th, 2022. On Wednesday, November 30th, 2022, Semantix will host a conference call to discuss its financial results. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time on November 30th, 2022 and will be webcast live on Semantix`s Investor Relations website at ir.semantix.ai/news-events/events. Parties interested in participating via telephone may register using this online form. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number...

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (TSXV:SLHG; OTCQX: SLHGF) (“Skylight Health” or the “Company”), a healthcare platform combining technology and analytics, focused on transitioning patients into value-based care to drive better health outcomes and experiences in the United States, today announces that the Company has been granted an extension by the TSX Venture Exchange (the “TSXV“) to complete the final tranche of the previously announced US$5 million financing in the form of convertible debentures (“Financing”) by no later than December 21, 2022. The terms of the Financing remain unchanged from those described in the press release dated October 21, 2022, found here, and the Financing remains subject to receipt of all necessary approvals, including the approval of the TSXV. About...

Company to Host Conference Call November 22, 2022 at 10:00 am ET VANCOUVER, British Columbia and AUSTIN, Texas, Nov. 21, 2022 (GLOBE NEWSWIRE) — Inspire Semiconductor Holdings Inc. (TSXV: INSP) (“InspireSemi” or the “Company”), a chip design company that has built a technology foundation to deliver revolutionary performance, today announced financial results for the third quarter ended September 30, 2022 and provided a business update. All financial information is presented in United States (“US”) Dollars unless otherwise indicated. “In the third quarter, we made substantial progress executing on our plan to become a game-changer in the accelerated computing solution industry,” said Ron Van Dell, CEO of InspireSemi. “We are in the final development stages of our anxiously awaited next-generation Thunderbird compute accelerator,...

Top-line data from the Phase 3 clinical trial evaluating AR-301 for the treatment of VAP expected in December of this year LOS GATOS, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its third quarter ended September 30, 2022. Third Quarter HighlightsClosed enrollment in the Company’s Phase 3 study evaluating AR-301 for the treatment of Ventilator Associated Pneumonia (VAP). Aridis expects to report top-line data from this study in December 2022. Continued enrollment in the Company’s Phase 2a study of AR-501 targeting cystic fibrosis (CF), conducted in collaboration with funding support from the Cystic...

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — YAMANA GOLD INC. (TSX: YRI, NYSE: AUY, LSE: AUY) (“Yamana” or the “Company”) announces that it has filed the required notice setting the record and meeting dates in respect of the special meeting of shareholders to consider the previously announced proposed transaction (the “Proposed Transaction”) with Agnico Eagle Mines Limited and Pan American Silver Corp. (“Pan American Silver”). The record date, which is the date of record for determination of shareholders entitled to receive notice of and vote at the special meeting of shareholders, is set as December 14, 2022 and the special meeting of shareholders will be convened on January 31, 2023. Yamana has been advised that a Pan American Silver shareholder meeting is scheduled for the same day as the Company’s special meeting of shareholders. Further...